A

AbbVie

Global biopharmaceutical company developing medicines

Senior Director - Pipeline Market Access Strategy, Oncology

Corporate StrategyConfirmed live in the last 24 hours
Full-timeMettawa, IL, USAHybrid

About the Job

Requirements

  • An advanced degree (MBA, MPH, PhD, PharmD, or equivalent) in business, health economics, public policy, life sciences, or a related field is required.
  • A bachelor's degree in a scientific, business, or public health discipline is required as a minimum baseline.
  • A minimum of 12–15 years of progressive, senior-level experience in market access, pricing, reimbursement, HEOR, or a closely related pharmaceutical or biopharmaceutical function is required, with a substantial portion focused on pipeline and pre-launch strategy.
  • Demonstrated expertise in global market access, including working knowledge of HTA processes, payer evidence requirements, pricing and reimbursement frameworks, and access decision-making dynamics across major international markets, including the US, EU5, and Japan, is required.
  • Proven experience shaping clinical development strategy from a market access and outcomes evidence perspective, including contributing to clinical trial design, endpoint selection, and Integrated Evidence Plan development with R&D teams, is required.
  • A strong track record of leading and developing high-performing teams in a matrixed, multinational environment, including managing direct reports and influencing cross-functional partners without direct authority, is required.
  • Experience across multiple therapeutic areas is an asset, though deep expertise in at least one therapeutic area is required.

Responsibilities

  • Own the end-to-end integrated access strategy for all pre-launch and development-stage assets within the assigned Business Unit, addressing evidence needs, policy considerations, pricing potential, and commercial considerations through regulatory submission.
  • Represent pipeline market access strategies at Business Unit governance forums, communicating access risks, opportunities, and strategic direction.
  • Represent market access in pipeline Business Development opportunities.
  • Lead prioritization exercises across the pipeline portfolio to allocate resources and strategic attention to assets with the greatest access complexity and business impact.
  • Create and optimize launch strategies that account for the IRA, MFN, US channel dynamics, and other market forces to support sequencing across indications and geographies.
  • Define and deliver the Access Roadmap for each pipeline asset by development phase, anticipated launch timing, and global evidence deliverables.
  • Partner with R&D and Regulatory teams from Phase I/II onward to embed access-relevant endpoints, comparators, and trial design elements, ensuring studies address payer and HTA evidence standards at launch and partnering with affiliates.
  • Define and champion Target Product Profiles from a market access perspective, translating payer value requirements into clinical and evidence-generation guidance for asset teams.
  • Generate and maintain global payer and HTA evidence requirements across major markets, including the US, EU5, Japan, and emerging markets, and ensure development programs proactively address evidence gaps affecting access and reimbursement.
  • Provide strategic direction to the US Pipeline Strategy Lead and International Pipeline Strategy Lead, integrating domestic and global perspectives into a Business Unit-level pipeline access strategy.
  • Align US payer strategy, formulary positioning, and value communication frameworks with international HTA, pricing, and reimbursement approaches while adapting to local market requirements.
  • Anticipate cross-market reference pricing dynamics, parallel trade risks, and HTA precedent effects, incorporating them into early pipeline access strategy.
  • Develop and execute a pipeline-to-launch transition framework with US and International Pipeline Strategy Leads, preparing market access strategies, payer evidence packages, and reimbursement submissions ahead of regulatory approval.
  • Collaborate with US and international commercial, medical, and market access teams to transfer knowledge and hand off strategy at regulatory approval, including payer communication plans, launch sequencing strategies, and country-level access readiness assessments.
  • Lead cross-functional launch readiness reviews with US and International teams to identify and resolve access gaps in evidence, pricing approvals, and formulary positioning before approval.
  • Ensure affiliate and in-country market access teams have globally aligned value messages, health economic tools, and reimbursement dossiers well in advance of launch.
  • Provide strategic direction and partnership to HEOR, R&D, Regulatory, Global Commercial Development, Global Marketing, Government Affairs, and Business Development, integrating market access perspectives into pipeline asset decisions.
  • Lead Integrated Evidence Plan development with HEOR, aligning real-world evidence, health economic modeling, and outcomes research strategies with anticipated payer and HTA requirements at launch.
  • Partner with Government Affairs to anticipate and shape policy and reimbursement developments, embedding policy risks and opportunities into pipeline access strategies.
  • Collaborate with Global Commercial Development and Global Marketing to align pipeline access strategies with brand positioning, indication sequencing, and long-range commercial forecasts.
  • Work with Business Development to assess market access potential for in-licensing, partnership, and acquisition opportunities, providing payer landscape assessments, reimbursement probability analyses, and access risk evaluations.
  • Establish and communicate access-based licensing priorities that account for payer value evidence requirements, competitive access dynamics, and global pricing sustainability.
  • Serve as the access subject matter expert in due diligence, assessing payer readiness and evidence maturity of externally sourced pipeline assets.
  • Represent pipeline market access priorities at senior leadership governance forums, portfolio review committees, and cross-Business Unit strategy sessions.
  • Build, develop, and retain a high-performing pipeline access team, providing mentorship, career development, and performance management for direct and indirect reports across US and international functions.
  • Foster a culture of innovation, rigor, and affiliate-centricity, incorporating affiliate launch needs, in-country market dynamics, and local payer requirements into global strategy development.

Desired Qualifications

  • Formal training or demonstrated expertise in health technology assessment, health economics, outcomes research, or pharmaceutical development is strongly preferred.
  • Experience supporting Business Development activities, including asset due diligence, licensing evaluations, and access-based valuation assessments, is highly preferred.

About the Company

AbbVie

Global biopharmaceutical company developing medicines

AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.

Company size
10,001+
Company stage
IPO
Headquarters
North Chicago, IL
Founded
1888

Recently Posted Jobs

Explore more opportunities at AbbVie

See more jobs